The estimates used by U.S. Federal agencies and others to value reductions in fatality risks generally reflect adults’ willingness to trade income for changes in their own risks. Several studies have now been completed that address the value of risk reductions to children. We review these studies for quality and applicability based on selection and evaluation criteria derived from recent discussions of best practices. To limit the effects of between-study variability, we searched for studies that estimate values for both adults and children using a consistent approach. We find seven studies that meet our selection criteria. The studies suggest that the value for children exceeds the value for adults by a factor of 1.2 to 3.0, with a midpoin...
We examine effects of age on valuation of mortality and morbidity risks using a two-stage contingent...
Objectives: Evidence comparing utilities for adults and children consistently report higher utility ...
This Article provides the first comprehensive analysis of how cost-benefit analysis should value chi...
In benefit-cost analysis, fatality risk reductions are usually valued based on estimates of adults’ ...
The estimates used by U.S. Federal agencies and others to value reductions in fatality risks general...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
The protection of children's health has recently become a mandated priority for federal policy maker...
The value of mortality risk reductions, conventionally expressed as the value per statistical life (...
Estimates of the Value of Statistical Life (VSL) provide a vital input to a variety of policy decisi...
Empirical results presented in this paper suggest that parents ’ marginal willingness to pay (MWT...
Empirical results presented in this paper suggest that parents’ marginal willingness to pay (MWTP) f...
We examine effects of age on valuation of mortality and morbidity risks using a two-stage contingent...
Empirical results presented in this paper suggest that parents’ marginal willingness to pay (MWTP) f...
We examine effects of age on valuation of mortality and morbidity risks using a two-stage contingent...
Objectives: Evidence comparing utilities for adults and children consistently report higher utility ...
This Article provides the first comprehensive analysis of how cost-benefit analysis should value chi...
In benefit-cost analysis, fatality risk reductions are usually valued based on estimates of adults’ ...
The estimates used by U.S. Federal agencies and others to value reductions in fatality risks general...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
This article reviews the economics literature dealing with valuation of reduced environmental risks ...
The protection of children's health has recently become a mandated priority for federal policy maker...
The value of mortality risk reductions, conventionally expressed as the value per statistical life (...
Estimates of the Value of Statistical Life (VSL) provide a vital input to a variety of policy decisi...
Empirical results presented in this paper suggest that parents ’ marginal willingness to pay (MWT...
Empirical results presented in this paper suggest that parents’ marginal willingness to pay (MWTP) f...
We examine effects of age on valuation of mortality and morbidity risks using a two-stage contingent...
Empirical results presented in this paper suggest that parents’ marginal willingness to pay (MWTP) f...
We examine effects of age on valuation of mortality and morbidity risks using a two-stage contingent...
Objectives: Evidence comparing utilities for adults and children consistently report higher utility ...
This Article provides the first comprehensive analysis of how cost-benefit analysis should value chi...